| AFB1+antimutagen(s)
dose ( m g/plate) |
S. typhimurium TA98+S9 |
S. typhimurium TA100+S9 |
| No of revertants |
±SD |
% of
inhibition |
No of revertants |
±SD |
% of
inhibition |
| 10+0 |
471 |
94 |
|
762 |
90 |
|
| 1+0 |
559 |
100 |
|
703 |
72 |
|
| 10+0.3EA |
446 |
67 |
-5 |
729 |
114 |
-4 |
| 10+3EA |
467 |
81 |
-1 |
701 |
129 |
-8 |
| 10+30EA |
406 |
119 |
-14 |
685 |
131 |
-10 |
| 10+300EA |
127** |
42 |
-73 |
501** |
134 |
-34 |
| 10+0.3CRC |
446 |
117 |
-5 |
666 |
141 |
-13 |
| 10+3CRC |
456 |
99 |
-3 |
641 |
138 |
-16 |
| 10+30CRC |
67** |
25 |
-86 |
522** |
212 |
-32 |
| 10+300CRC |
9** |
5 |
-98 |
226** |
108 |
-70 |
| 10+0.3EA+0.3CRC |
434 |
41 |
-8 |
605* |
168 |
-21 |
| 10+3EA+3CRC |
474 |
38 |
+1 |
601* |
174 |
-21 |
| 10+30EA+30CRC |
73** |
30 |
-85 |
480** |
193 |
-37 |
| 10+300EA+300CRC |
12** |
7 |
-98 |
146** |
67 |
-81 |
| 1+0.3EA |
548 |
56 |
-2 |
703 |
100 |
0 |
| 1+3EA |
573 |
26 |
+3 |
681 |
88 |
-3 |
| 1+30EA |
449* |
88 |
-20 |
634 |
158 |
-10 |
| 1+300EA |
54** |
18 |
-90 |
244** |
109 |
-65 |
| 1+0.3CRC |
591 |
39 |
+6 |
644 |
108 |
-8 |
| 1+3CRC |
575 |
22 |
+3 |
663 |
80 |
-6 |
| 1+30CRC |
103** |
31 |
-82 |
532** |
129 |
-24 |
| 1+300CRC |
36** |
22 |
-94 |
147** |
41 |
-79 |
| 1+0.3EA+0.3CRC |
511 |
81 |
-9 |
581 |
166 |
-17 |
| 1+3EA+3CRC |
481**▼ |
73 |
-14 |
516**▼ |
104 |
-27 |
| 1+30EA+30CRC |
57**▼ |
8 |
-90 |
193**▼ |
89 |
-73 |
| 1+300EA+300CRC |
23** |
13 |
-96 |
107** |
33 |
-85 |
| control-DMSO |
22 |
6 |
|
101 |
14 |
|
SD: Standard Deviation
*Statistically significant difference between the sample with mutagen and antimutagen(s) and the sample with specific mutagen (1) p < 0.05
**Statistically significant difference between the sample with mutagen and antimutagen(s) and the sample with specific mutagen (1) p < 0.01
▼Statistically significant difference between the sample with combination of antimutagens and samples with specific antimutagen |
